Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Distribute MitoSciences' Antibodies and Immunoassays

NEW YORK (GenomeWeb News) – Invitrogen said today that it will become the exclusive North American distributor of all of MitoSciences products, which includes monoclonal antibodies and immunoassays for researching mitochondrial proteins and diseases.
 
Invitrogen said that as MitoSciences’ existing distribution agreements expire, it would take over those agreements worldwide on an exclusive basis. The firms did not disclose how many of those distribution agreements exist.
 
The pact will add more than 200 new products to Invitrogen’s antibody and kit catalog, the Carlsbad, Calif.-based firm said.
 
August Sick, vice president and general manager of Invitrogen’s Cellular Analysis Business Unit, said in a statement that Invitrogen plans to offer prepackaged kits in the future that will combine MitoSciences’ technology with its fluorescent labeling and cell separation technologies for mitochondrial research.
 
The firms did not disclose financial or any other additional terms of the alliance.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.